REPORTING OF ADVERSE DRUG REACTIONS BY PATIENTS IN BULGARIA

REPORTING OF ADVERSE DRUG REACTIONS BY PATIENTS IN BULGARIA

Blog Article

Many adverse drug reactions (ADRs) are difficult to detect or predict, as they are rare or have a long latency period.They only become apparent after the medicine is released on the market.The primary goal of pharmacovigilance is the early recognition of unexpected ADRs after marketing authorization.Reporting suspected ADRs by patients has the potential to increase knowledge about the possible harmful effects of medicines.

The publication aims to examine and analyze the participation of patients in the Plastic Car pharmacovigilance system in Bulgaria.Materials and methods: We conducted a web-based, anonymous survey to collect data on the participation of 440 Bulgarian patients in the reporting of ADRs.IBM SPSS (Statistical Package for the Social Sciences) version 26 was utilized for data processing.Results: There is an increase in the number of reported by patients ADRs for the period 2016-2020.

However, a relatively low and unsatisfactory level of spontaneous patient reports is still observed.The conducted survey reveals that patients in Bulgaria have a high level of awareness regarding the essence of medication Board Game safety.The percentage of people who are aware of the possibility to directly report ADRs to the Bulgarian Drug Agency is also high.There is a lack of awareness regarding the reactions that need to be reported, as well as the methods of reporting.

Conclusions: It is necessary to increase awareness about the importance of reporting ADRs.Significantly improving health literacy will greatly contribute to the effective functioning of the pharmacovigilance system.